…
Doctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom. The company offers services in the areas of medical letters, imaging support, blood testing, and mental health support, as well as comprehensive health checks, health solutions, specialist care pathways, physiotherapy support, and GP and ACP appointments. The company provides treatments for allergies, intolerances, colds, flu, minor illnesses, gut health, joints and muscles, lifestyle support, men's and women's health, mental health, sexual health, and skin conditions, as well as technology platform licensing and digital design services. Doctor Care Anywhere Group PLC was founded in 2013 and is headquartered in Mayfair, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Doctor Care Anywhere Group Plc operates a digital primary-care platform offering remote consultations and related clinical services to patients, employers and payers, primarily in the UK. Long-term growth drivers include rising adoption of virtual care, pressure on health-system costs that may support remote services, and potential expansion of payer and employer contracts, which could support scalable recurring revenue.
Key risks include intense competition and price pressure, regulatory and reimbursement uncertainty, dependence on winning or retaining payer and employer contracts, and execution and profitability challenges common to digital health providers.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 1.22M | -5.27M | -8.86M | -22.29M | -20.53M |
| Minority interest | - | - | - | - | 0.00M |
| Net income | 1.17M | -6.29M | -10.05M | -22.03M | -20.22M |
| Selling general administrative | - | 17.05M | 22.36M | 23.78M | 23.11M |
| Selling and marketing expenses | - | 0.80M | 0.71M | 1.86M | 3.39M |
| Gross profit | 14.12M | 22.42M | 17.69M | 13.42M | 11.02M |
| Reconciled depreciation | - | 2.30M | - | - | - |
| Ebit | 1.73M | -4.45M | -8.17M | -19.57M | -20.45M |
| Ebitda | 4.21M | -2.15M | -5.78M | -19.71M | -20.39M |
| Depreciation and amortization | 2.48M | 2.30M | 2.39M | -0.14M | 0.07M |
| Operating income | 1.73M | -4.56M | -8.40M | -19.57M | -20.45M |
| Other operating expenses | 36.70M | 43.89M | 46.86M | 49.99M | 45.90M |
| Interest expense | 0.75M | 0.83M | 0.51M | 0.08M | 0.14M |
| Tax provision | - | -0.14M | -0.69M | -0.26M | -0.31M |
| Interest income | - | 0.12M | 0.05M | 0.00M | 0.00M |
| Net interest income | - | -0.71M | -0.46M | -0.08M | -0.14M |
| Extraordinary items | - | -1.15M | -1.88M | - | - |
| Income tax expense | 0.05M | -0.14M | -0.69M | -0.26M | -0.31M |
| Total revenue | 38.43M | 39.33M | 38.46M | 30.42M | 25.59M |
| Total operating expenses | 12.39M | 29.52M | 26.09M | 32.99M | 31.33M |
| Cost of revenue | 24.31M | 16.91M | 20.77M | 17.00M | 14.57M |
| Total other income expense net | -0.51M | -0.71M | -0.46M | -2.72M | -0.07M |
| Net income from continuing ops | - | -5.14M | -8.17M | -22.03M | -20.22M |
| Net income applicable to common shares | - | -6.29M | -10.05M | -22.03M | -20.22M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 17.18M | 14.99M | 36.63M | 22.01M | 36.66M |
| Intangible assets | - | 5.83M | - | 6.45M | 10.98M |
| Other current assets | 1.01M | 1.77M | 5.57M | 1.85M | 0.46M |
| Total liab | 16.16M | 15.64M | 32.27M | 9.72M | 7.20M |
| Total stockholder equity | 1.02M | -0.65M | 4.36M | 12.29M | 29.46M |
| Other current liab | 3.98M | 4.16M | 5.71M | 1.21M | 1.48M |
| Common stock | 0.08M | 0.08M | 0.15M | 0.08M | 0.07M |
| Capital stock | - | - | - | 0.08M | 0.07M |
| Retained earnings | -61.16M | -62.42M | -104.86M | -46.08M | -24.05M |
| Other liab | - | - | - | 0.96M | 0.28M |
| Good will | - | - | - | 2.68M | 5.18M |
| Other assets | - | - | 0.00M | - | - |
| Cash | 6.56M | 4.41M | 11.32M | 5.41M | 17.07M |
| Total current liabilities | 6.15M | 6.82M | 18.24M | 8.14M | 5.90M |
| Current deferred revenue | 0.77M | - | 1.15M | - | - |
| Net debt | 3.83M | 3.86M | 9.23M | -5.41M | -17.07M |
| Short term debt | 0.65M | 0.21M | 7.92M | 0.00M | 0.00M |
| Short long term debt total | 10.39M | 8.27M | 20.55M | - | - |
| Other stockholder equity | 62.10M | 56.21M | 109.07M | 2.08M | 3.29M |
| Property plant equipment | - | - | - | 1.22M | 1.89M |
| Total current assets | 9.55M | 8.77M | 21.66M | 9.69M | 21.66M |
| Long term investments | - | - | - | 1.97M | 2.11M |
| Net tangible assets | - | - | - | 3.16M | 18.48M |
| Short term investments | - | 0.88M | - | - | - |
| Net receivables | 1.98M | 1.72M | 4.76M | 2.44M | 2.97M |
| Long term debt | - | - | - | - | 0.00M |
| Inventory | - | - | 0.00M | - | 1.17M |
| Accounts payable | 0.76M | 2.46M | 3.47M | 8.14M | 5.90M |
| Accumulated other comprehensive income | - | 5.48M | - | 58.29M | 53.44M |
| Non currrent assets other | - | - | 11.15M | - | - |
| Non current assets total | 7.62M | 6.22M | 14.97M | 12.32M | 14.99M |
| Long term debt total | - | - | - | 0.62M | 1.02M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -1.65M | -2.24M | -2.34M | -4.50M |
| Change to liabilities | - | - | - | 0.00M | 0.00M |
| Total cashflows from investing activities | -2.29M | -1.65M | -2.24M | -2.34M | -4.50M |
| Net borrowings | - | -0.23M | 9.32M | -0.17M | -0.54M |
| Total cash from financing activities | -0.43M | -0.33M | 9.32M | 5.90M | -0.61M |
| Net income | 1.17M | -6.29M | -8.25M | -22.03M | -20.22M |
| Change in cash | 2.15M | -1.65M | 0.66M | -11.66M | -21.30M |
| Begin period cash flow | 4.41M | 6.06M | 5.41M | 17.07M | 38.36M |
| End period cash flow | 6.56M | 4.41M | 6.06M | 5.41M | 17.07M |
| Total cash from operating activities | 4.92M | 0.35M | -6.34M | -22.03M | -16.11M |
| Issuance of capital stock | - | - | - | 6.41M | 0.04M |
| Depreciation | 2.48M | 2.21M | 4.48M | 0.64M | 0.58M |
| Other cashflows from investing activities | - | -1.65M | -2.24M | 0.00M | -1.82M |
| Sale purchase of stock | - | - | - | -0.34M | -0.11M |
| Other cashflows from financing activities | - | -0.10M | -2.24M | 0.01M | -4.50M |
| Change to netincome | - | - | - | 4.73M | 2.71M |
| Capital expenditures | 0.07M | 0.01M | 2.33M | 2.34M | 2.69M |
| Change in working capital | - | 0.06M | 0.75M | 0.27M | 0.00M |
| Stock based compensation | - | 0.10M | - | - | - |
| Other non cash items | 1.27M | 4.43M | 1.91M | 22.03M | 20.22M |
| Free cash flow | 4.85M | 0.35M | -8.67M | -24.38M | -18.80M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DOC Doctor Care Anywhere Group Plc |
-0.01 8.00% |
0.09 | 10.00 | - | 0.94 | 9.96 | 0.51 | 4.03 |
| PME Pro Medicus Ltd |
-3.10 1.49% |
205.13 | 81.98 | 106.38 | 83.13 | 43.70 | 74.38 | 95.34 |
| 4DX 4DMEDICAL Ltd |
-0.13 5.39% |
2.28 | - | - | 205.57 | 8.53 | 170.03 | -7.29 |
| CGS Cogstate Ltd |
-0.09 2.66% |
3.29 | 33.80 | 27.86 | 9.59 | 6.95 | 6.35 | 19.27 |
| AYA ARTRYA Ltd |
- -% |
3.50 | - | - | 20505.14 | 7.00 | 16927.51 | 0.33 |
Doctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom. The company offers services in the areas of medical letters, imaging support, blood testing, and mental health support, as well as comprehensive health checks, health solutions, specialist care pathways, physiotherapy support, and GP and ACP appointments. The company provides treatments for allergies, intolerances, colds, flu, minor illnesses, gut health, joints and muscles, lifestyle support, men's and women's health, mental health, sexual health, and skin conditions, as well as technology platform licensing and digital design services. Doctor Care Anywhere Group PLC was founded in 2013 and is headquartered in Mayfair, the United Kingdom.
19-21 Great Portland Street, Mayfair, United Kingdom, W1W 8QB
44 33 0088 4980
452
| Name | Title | Year Born |
|---|---|---|
| Dr. Bayju Thakar MBBS BSc | Consultant | NA |
| Mr. Mark Taylor | Interim Chief Exec. Officer | NA |
| Dr. Sally Johnson | Chief Medical Officer | NA |
| Dr. Tim Bray | Chief Medical Officer | NA |
| Ms. Martina Usher | Chief Risk Officer | NA |
| Bianca Foster | Company Sec. | NA |
| Mr. James Warren | Acting Chief Financial Officer | NA |
| Mr. Benjamin David Jemphrey Kent | Interim Chief Executive Officer | NA |
| Maaya Chaplin | Head of Marketing | NA |
| Mr. Jamie Aspinall | Chief People Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.